Company Search:
Advanced Search
Sponsored Links
CSL Limited - ADR Company Snapshot
CSL Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares CSL Limited with three other companies in this sector in the United States: Eisai Company Limited (2019 sales of $5.79 billion of which 88% was Pharmaceutical Business), Daiichi Sankyo Company Limited ($8.38 billion of which 93% was Prescription drugs), and Catalent Inc ($2.52 billion of which 35% was Softgel Technologies).

Sales Analysis. CSL Limited reported sales of $8.54 billion for the fiscal year ending June of 2019. This represents an increase of 7.9% versus 2018, when the company's sales were $7.92 billion. Sales at CSL Limited have increased during each of the previous five years (and since 2014, sales have increased a total of 55%). Sales of Seqirus saw an increase of 11.8% in 2019, from $910.40 million to $1.02 billion.
  Stock Performance Chart for CSL Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 96.47
(Figures in U.S. Dollars)
1 Week 0.2%   13 Weeks 6.1%  
4 Weeks 16.3%   52 Weeks 47.0%  
CSL Limited - ADR Key Data:
  Ticker: CSLLY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 8,538,606,751
(Year Ending Jan 2020).
Employees: 25,000
  Currency: U.S. Dollars Market Cap: 87,428,567,658
  Fiscal Yr Ends: June Shares Outstanding: 906,277,264
  Share Type: Common Closely Held Shares: 4,308,912
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.